Skip to content

Clinical trials

Observational End Stage Liver Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: End Stage Liver Disease Phase: Observational Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20102
20117
20123
20132
20142
20154
20162
20183
20192
20202
20213
20227
20233
20243
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Unknown status12
Recruiting7
Active, not recruiting3
Terminated3
Enrolling by invitation2
Suspended1
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic3
Arbor Research Collaborative for Health2
Asan Medical Center2
Centre hospitalier de l'Université de Montréal (CHUM)2
Seoul National University Hospital2
Tongji Hospital2
Virginia Commonwealth University2
Assiut University1
Azienda Ospedaliera di Padova1
Baylor Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
End Stage Liver Disease54
Liver Cirrhosis9
Fibrosis6
Liver Diseases6
Frailty5
Liver Failure, Acute5
Acute-On-Chronic Liver Failure4
Carcinoma, Hepatocellular3
Hepatitis B3
Hepatitis C3

Trials

Showing 76 to 54 of 54. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.